全文获取类型
收费全文 | 15659篇 |
免费 | 973篇 |
国内免费 | 103篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 351篇 |
妇产科学 | 882篇 |
基础医学 | 1948篇 |
口腔科学 | 320篇 |
临床医学 | 1733篇 |
内科学 | 3218篇 |
皮肤病学 | 305篇 |
神经病学 | 1143篇 |
特种医学 | 517篇 |
外科学 | 2088篇 |
综合类 | 538篇 |
一般理论 | 8篇 |
预防医学 | 815篇 |
眼科学 | 428篇 |
药学 | 1095篇 |
中国医学 | 126篇 |
肿瘤学 | 1088篇 |
出版年
2023年 | 57篇 |
2022年 | 156篇 |
2021年 | 363篇 |
2020年 | 157篇 |
2019年 | 315篇 |
2018年 | 420篇 |
2017年 | 257篇 |
2016年 | 285篇 |
2015年 | 468篇 |
2014年 | 547篇 |
2013年 | 767篇 |
2012年 | 1116篇 |
2011年 | 1179篇 |
2010年 | 789篇 |
2009年 | 645篇 |
2008年 | 897篇 |
2007年 | 906篇 |
2006年 | 885篇 |
2005年 | 835篇 |
2004年 | 777篇 |
2003年 | 659篇 |
2002年 | 633篇 |
2001年 | 566篇 |
2000年 | 545篇 |
1999年 | 403篇 |
1998年 | 148篇 |
1997年 | 149篇 |
1996年 | 143篇 |
1995年 | 110篇 |
1994年 | 95篇 |
1993年 | 63篇 |
1992年 | 189篇 |
1991年 | 157篇 |
1990年 | 123篇 |
1989年 | 119篇 |
1988年 | 120篇 |
1987年 | 91篇 |
1986年 | 81篇 |
1985年 | 69篇 |
1984年 | 57篇 |
1983年 | 36篇 |
1982年 | 32篇 |
1981年 | 29篇 |
1980年 | 22篇 |
1979年 | 42篇 |
1978年 | 27篇 |
1977年 | 26篇 |
1976年 | 22篇 |
1975年 | 26篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
2.
SK Raina 《Journal of postgraduate medicine》2015,61(3):213-Sep;61(3):213
3.
4.
5.
Tien‐Yao Tsai Iat‐Lon Leong Ka‐Shun Cheng Lian‐Ru Shiao Tzu‐Hui Su Kar‐Lok Wong Paul Chan Yuk‐Man Leung 《Fundamental & clinical pharmacology》2019,33(1):52-62
A pathological feature in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC). Oxidized low‐density lipoprotein (LDL), known to accumulate in the atherosclerotic arterial walls, impairs endothelium‐dependent relaxation and causes EC apoptosis. A major bioactive ingredient of the oxidized LDL is lysophosphatidylcholine (LPC), which at higher concentrations causes apoptosis and necrosis in various EC. There is hitherto no report on LPC‐induced cytotoxicity in brain EC. In this work, we found that LPC caused cytosolic Ca2+ overload, mitochondrial membrane potential decrease, p38 activation, caspase 3 activation and eventually apoptotic death in mouse cerebral bEND.3 EC. In contrast to reported reactive oxygen species (ROS) generation by LPC in other EC, LPC did not trigger ROS formation in bEND.3 cells. Pharmacological inhibition of p38 alleviated LPC‐inflicted cell death. We examined whether heparin could be cytoprotective: although it could not suppress LPC‐triggered Ca2+ signal, p38 activation and mitochondrial membrane potential drop, it did suppress LPC‐induced caspase 3 activation and alleviate LPC‐inflicted cytotoxicity. Our data suggest LPC apoptotic death mechanisms in bEND.3 might involve mitochondrial membrane potential decrease and p38 activation. Heparin is protective against LPC cytotoxicity and might intervene steps between mitochondrial membrane potential drop/p38 activation and caspase 3 activation. 相似文献
6.
Multidisciplinary predialysis education and team care (MDC) may slow the decline in renal function in patients with chronic kidney disease (CKD). However, associations between unexpected return during MDC and progression of renal dysfunction have not been characterized in patients with CKD. Our study aimed to determine the association between exacerbation of renal dysfunction and the frequency of unexpected return during follow-up.A total of 437 patients with CKD receiving multidisciplinary care between January 2009 and June 2013 at the Shin-Kong Wu Ho-Su Memorial Hospital were included in this retrospective observational cohort study, and multiple imputations were performed for missing data. The predictor was the frequency of unexpected return for follow-up during the first year after entering MDC. Main outcome was monthly declines in estimated glomerular filtration rates (eGFR). Moreover, the demographic data, comorbidities, history of medication, and routine laboratory data for patients with CKD were collected.Among all patients, 59.7% were male, the mean age at initiation of MDC was 69.4 ± 13.2 years, and the duration of follow-up was 21.4 ± 3.3 months. The subjects were divided into 2 groups according to frequencies of follow-up (≤4 and > 4 visits) during the 1st year of MDC. The patients with CKD were regularly followed up every 3 months as a part of MDC in our hospital, and patients who returned for more than 4 follow-up visits were included in the unexpected return group. In crude regression analyses, unexpected return was significantly associated with higher monthly declines of eGFR (β = 0.092, 95% confidence interval, 0.014–0.170). This association remained after adjustments for multiple variables, and subgroup analyses of unexpected return showed that male gender, older age, CKD stage 1 to 3, hypertension, history of coronary artery disease, and use of renin–angiotensin system blockade were significantly associated with declines in renal function.In conclusion, unexpected return for follow-up during the 1st year of MDC was significantly associated with the deterioration of renal function. 相似文献
7.
8.
9.
10.
目的:直肠腺瘤和其他疑似为良性的病变应用经肛门内镜切除术并未普及。该项研究旨在评估经肛门内镜切除术的效能和安全性。方法:回顾性研究分析在1993-2004年之间3所斯德哥尔摩医院中经肛门内镜切除术的患,内容包括患自身及病变特性、并发症、随访时间和复发率。结果:180例中共131例行经肛门内镜切除术。160例经组织学诊断为腺瘤,12例为癌瘤,其余8例分别为增生、纤维化或正常黏膜。直肠腺瘤患中,77例仅行单次经肛门内镜切除术,16例因巨大腺瘤而多次行该手术,27例因复发而需另行经肛门内镜切除术或其他手术。中位复发时间为7个月,但未出现直肠癌。16例手术患出现并发症。2例患必须行Hartman手术,1例因肠穿孔,另1例因出血。手术期间无死亡。未复发的中位随访期为32个月(极差0—67)。[编按] 相似文献